MaxL Meets the Money Series: MIG & TVM

MAxL Meets the Money Series: Meet MIG & TVM

Acquiring funding is a key challenge for early-stage start-ups. At MAxL, we want to reach out to the other side of the table: What is the investment strategy of each fund? How do seed stage investors come to their decision? What should look look out for in a term sheet? What are they looking for when reviewing a pitch?

MAxL Meets the Money is an event series hosted by BioM’s Munich Accelerator Life Sciences and Medicine (MAxL). We would like to give pre-seed projects and start-ups in search for funding the opportunity to connect with relevant investorsin an informal, casual setting.

When? 23 September 2025

Where? At MAxL, Am Klopferspitz 19a, 82152 Martinsried

Registration: Please register here.

AGENDA:

4:00 pm Get to know MIG and TVM

4:40 pm Ask me anything – take the opportunity to gain new insights

5:00 pm Networking – enjoy an informal exchange with investors and your peers

For this edition, we are delighted to welcome:

Dr. Amy Kao, Senior Associate TVM Capital.

Prior to TVM, Amy focused on building and funding healthtech opportunities at Oxford Science Enterprises, the largest university-affiliated investment company in the world. Amy was previously a M&A consultant at EY Global, advising transaction strategies for health care & life science corporations. She has hands-on experience in venture ideation from Merck KGaA’s Innovation Centre and company creation from her role as Chief of Staff at a Parkinson’s and Dementia digital health start-up. Her academic work in the gut-brain axis has been published in Nature’s Translational Psychiatry and other high-impact journals. Amy holds a DPhil in Neuroscience from the University of Oxford.

Dr. Fei Tian, Principal in the MIG Capital Life Science investment team.

She is a healthcare innovation expert with a profound background in medicine and biology and many years of investment experience in the life science venture capital industry. Before joining MIG, Fei worked for yabeo Venture Tech and Vesalius Biocapital. Fei studied medicine at Tongji University in PR China and worked as an emergency room physician. She then completed her doctorate in oncology and stem cell research at Ludwig-Maximilians-Universität and Klinikum. Her membership on the Board of Directors at SciRhom, Liva, and Temedica, brings expertise in venture development and biotech value creation strategy, following the goal of enabling disruptive innovations with promises of high impact for the future of medicine.

MAxL Meets the Money is an exclusive event for pre-seed projects and startups of MAxL and the BioM startup network.

For more info, reach out to:

Regina Abendroth Programme and Community Manager MAxL

+49 (0)89 / 89 96 79-31

abendroth@bio-m.org

Best regards, Your MAxL Team

Leyton Office Hours @ MAxL: Secure your slot to discuss funding options for your life sciences preseed project, startup or SME!

Following our successful event in May this year, we want to give you the opportunity to delve even deeper and discuss your specific projects and funding plans in a confidential setting.

When? 8 October 2025, 11.00 am

Where? At MAxL, Am Klopferspitz 19a, 82152 Martinsried

Registration: Please register and book your slot ahead with Daniel Niedermaier (dniedermaier@leyton.com) to ensure someone with the required focus and expertise will be available to you.

Leyton is an international funding consultancy with over 25 years of experience. The team of highly skilled technical and financial specialists supports you throughout the whole funding process: from the application to the disbursement of your funding.

Leyton experts will be onsite at MAxL for individual 1:1 meeting slots.

Onsite for you:

Daniel Niedermaier – Business Developer.

Daniel Niedermaier is a trained bioengineer and has advised numerous companies on their funding opportunities, from start-ups and SMEs to large corporations. He knows the challenges companies of all sizes and indus-tries face.

Dr. Saskia Graf – Teamlead Scientific Consulting.

As an experienced funding consultant, Dr. Saskia Graf supports companies in applying for national and international funding. Her areas of expertise lie in health research, biotechnology and medical technology.

Dr. Petra Schuhmann – Senior Scientific Consultant.

Dr. Petra Schuhmann holds a doc-torate in biology and has several years of research experience in the fields of molecular and microbiology. She has successfully supported numerous companies in receiving R&D funding.

Iwona Graichen – Teamlead Financial Consulting.

As an experienced financial consult-ant, Iwona Graichen ensures that funding applications are audit-proof and that the maxi-mum possible costs are claimed. This event targets: Pre-Seed projects, Start-ups and SMEs within the biotech and medtech fields, who would like to fund their innovation projects and strengthen their competitive advantage.

We are looking forward to your participation and an interesting exchange!

Best regards, Your MAxL Team